UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease

The New England journal of medicine, 2017-02, Vol.376 (5), p.429-439

2017

Volltextzugriff (PDF)

Amplified gene expression in CD59-transfected Chinese hamster ovary cells confers protection against the membrane attack complex of human complement

The Journal of biological chemistry, 1991-07, Vol.266 (20), p.13418-13422

1991

Volltextzugriff (PDF)

Contribution of the N-linked carbohydrate of erythrocyte antigen CD59 to its complement-inhibitory activity

The Journal of biological chemistry, 1992-04, Vol.267 (12), p.8404-8410

1992

Volltextzugriff (PDF)

Reoxygenation of hypoxic HUVECs in human sera augments nuclear NF-κB translocation and expression of vascular cell adhesion molecule-1 (VCAM-1): Inhibition with anti-human C5 therapy

Molecular immunology, 1998-04, Vol.35 (6-7), p.335-335

1998

Volltextzugriff (PDF)

Molecular and Functional Analysis of Porcine E-Selectin Reveals a Potential Role in Xenograft Rejection

Biochemical and biophysical research communications, 1994-10, Vol.204 (2), p.763-771

1994

Volltextzugriff (PDF)

Anti-C5 single chain antibody therapy blocks complement & leukocyte activation and reduces myocardial tissue damage in CPB patients

Molecular immunology, 1998-04, Vol.35 (6-7), p.397-397

1998

Volltextzugriff (PDF)

Cyclosporine-Induced Sympathetic Activation and Hypertension after Heart Transplantation

The New England journal of medicine, 1990-09, Vol.323 (11), p.693-699

1990

Volltextzugriff (PDF)

Sintering prevention and phase transformation of FePt nanoparticles

Journal of magnetism and magnetic materials, 2004-12, Vol.284, p.336-341

2004

Volltextzugriff (PDF)

A Clinical Therapeutic Trial of Cyclosporine in Myasthenia Gravis

Annals of the New York Academy of Sciences, 1993-06, Vol.681 (1), p.539-551

1993

Volltextzugriff (PDF)

Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis

The New England journal of medicine, 1987-03, Vol.316 (12), p.719

1987

Volltextzugriff (PDF)

Developing a model of a professional veterinary drug label

Journal of the American Veterinary Medical Association, 1996-07, Vol.209 (1), p.83

1996

Volltextzugriff (PDF)

effects of experimentally induced broncho-pneumonia on the pharmocokinetics and tissue depletion of gentamicin in healthy and pneumonic calves

Journal of veterinary pharmacology and therapeutics, 1991, Vol.14 (3), p.276-292

1991

Volltextzugriff (PDF)

Assessment of therapeutic plasmapheresis in demyelinating neurologic disorders

Southern medical journal (Birmingham, Ala.), 1986-08, Vol.79 (8), p.991-997

1986

Volltextzugriff (PDF)

Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone

Neurology, 1982-07, Vol.32 (7), p.739

1982

Volltextzugriff (PDF)

A Double-Blind Randomized Placebo-Controlled Trial to Assess the Safety and Efficacy of Cyclosporin A in the Treatment of Myasthenia Gravis

Annals of the New York Academy of Sciences, 1987-08, Vol.505 (1), p.854-856

1987

Volltextzugriff (PDF)

Persistence of transferable drug resistance in the lactose-fermenting enteric flora of swine following antimicrobial feeding

Canadian journal of comparative medicine, 1976-01, Vol.40 (2), p.175

1976

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease

Amplified gene expression in CD59-transfected Chinese hamster ovary cells confers protection against the membrane attack complex of human complement

Contribution of the N-linked carbohydrate of erythrocyte antigen CD59 to its complement-inhibitory activity

Reoxygenation of hypoxic HUVECs in human sera augments nuclear NF-κB translocation and expression of vascular cell adhesion molecule-1 (VCAM-1): Inhibition with anti-human C5 therapy

Molecular and Functional Analysis of Porcine E-Selectin Reveals a Potential Role in Xenograft Rejection

Anti-C5 single chain antibody therapy blocks complement & leukocyte activation and reduces myocardial tissue damage in CPB patients

Cyclosporine-Induced Sympathetic Activation and Hypertension after Heart Transplantation

Sintering prevention and phase transformation of FePt nanoparticles

A Clinical Therapeutic Trial of Cyclosporine in Myasthenia Gravis

Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis

Developing a model of a professional veterinary drug label

effects of experimentally induced broncho-pneumonia on the pharmocokinetics and tissue depletion of gentamicin in healthy and pneumonic calves

Assessment of therapeutic plasmapheresis in demyelinating neurologic disorders

Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone

A Double-Blind Randomized Placebo-Controlled Trial to Assess the Safety and Efficacy of Cyclosporin A in the Treatment of Myasthenia Gravis

Persistence of transferable drug resistance in the lactose-fermenting enteric flora of swine following antimicrobial feeding

Suchergebnisse filtern